CMND - Clearmind gains on exclusive global rights to psychedelic compounds for PTSD treatment
2024-05-07 08:31:48 ET
More on Clearmind Medicine Inc.
- Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation
- SciSparc gains as Clearmind partnership yields 3 new international patent applications
- Financial information for Clearmind Medicine Inc.